A Comprehensive Review of Neutrophilic Diseases
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 2×
“tein (IL-1RAcP), and IL-18 binds to IL-18R-alpha and IL-18Rbeta to initiate effector functions on target cells [103].”
BackgroundInterleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · cited 1×
“Several mutations associated with autoinflammatory disorders occur in the IL-1β pathway [100].”
BackgroundSecukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,682 · cited 1×
“Gain-offunction mutations in the nucleotide-binding domain, leucinerich repeat-containing receptor protein 3 gene (NLRP3) have been recognized as an aetiological factor of cryopyrinassociated periodic syndromes (CAPS), which typically present with neutrophil-rich urticarial skin lesions [102].”
BackgroundMcDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408 · cited 1×
“The term ‘autoinflammatory syndrome’ was initially introduced after the identification of the genetic causes of the most prevalent monogenic autoinflammatory disease worldwide— the autosomal recessive disease familial Mediterranean fever—and the discovery of TNF receptor mutations in the autosomal dominant disorder, T…”
BackgroundEuropean S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.
SWEET, R. B. (1964) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1964.tb14541.x · Cited by 1,049
Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis
Cohen, P. R. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-34 · Cited by 879 · cited 4×
“5- to 12-cm papules or plaques on the extremities, face and neck; and a dense neutrophilic infiltrate in the papillary dermis [21, 39, 40].”
BackgroundInfluentialJemec, G. B. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1014163 · Cited by 817 · cited 1×
“skin, most commonly the axillae, inguinal and anogenital regions [88].”
BackgroundSweet's syndrome (acute febrile neutrophilic dermatosis)
Driesch, P. V. D. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70215-2 · Cited by 655
Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., Forbes, A., Greenwood, R., & Probert, C. S. (2006) · Gut · doi:10.1136/gut.2005.074815 · Cited by 646 · cited 2×
“In particular, in the first study [121], infliximab has been reported to be superior to placebo in the treatment of PG [122], and in the second one, prednisolone and ciclosporin, the most used agents in PG treatment, did not differ in efficacy.”
BackgroundResultPyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria
Su, W. P. D., Davis, M. D. P., Weenig, R. H., Powell, F. C., & Perry, H. O. (2004) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02128.x · Cited by 580 · cited 1×
“Two different groups [21, 34] proposed similar diagnostic criteria which are reported in Table 2.”
BackgroundTreating inflammation by blocking interleukin-1 in humans
Dinarello, C. A., & van der Meer, J. W. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.008 · Cited by 549
[Sweet's syndrome. Acute febrile neutrophilic dermatosis].
Bt, G., & Holm, J. O. (1987) · PubMed · Cited by 504
Shoham, N. G., Centola, M., Mansfield, E., Hull, K. M., Wood, G., Wise, C. A., & Kastner, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135380100 · Cited by 493 · cited 14×
“On the other hand, Garzorz et al. proposed using the same acronym PAPASH to define the association of PG, acne, psoriasis, arthritis and HS observed in a 39-year-old woman [95].”
BackgroundInfluentialAutoinflammatory Disease Reloaded: A Clinical Perspective
Kastner, D. L., Aksentijevich, I., & Goldbach-Mansky, R. (2010) · Cell · doi:10.1016/j.cell.2010.03.002 · Cited by 487 · cited 1×
“allergy, high titer of circulating autoantibodies or autoreactive T cells [3].”
BackgroundWise, C. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.8.961 · Cited by 447 · cited 2×
“Genetic analysis allows to identify the presence of mutations involving the proline–serine–threonine–phosphatase interactive protein 1 (PSTPIP1) gene [78].”
BackgroundEtiology and Management of Pyoderma Gangrenosum: A Comprehensive Review
Ahronowitz, I., Harp, J., & Shinkai, K. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11595240-000000000-00000 · Cited by 409
Reichrath, J., Bens, G., Bonowitz, A., & Tilgen, W. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.10.006 · Cited by 407 · cited 1×
“Systematic reviews have primarily relied on anecdotal reports or retrospective case series [123, 124].”
BackgroundBennett, M. L., Jackson, J. M., Jorizzo, J. L., Fleischer, A. B., White, W. L., & Callen, J. P. (2000) · Medicine · doi:10.1097/00005792-200001000-00004 · Cited by 404 · cited 1×
“In contrast with classic PG, bullous PG is preferentially located on the upper extremities [25], including the back of the hands.”
BackgroundBinus, A. M., Qureshi, A. A., Li, V. W., & Winterfield, L. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10565.x · Cited by 404 · cited 3×
“Few cases are directly lethal, but PG patients have an increased risk of death [14, 20, 35, 36].”
BackgroundWalker, D. C., & Cohen, P. R. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90080-8 · Cited by 338
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
Alavi, A., French, L. E., Davis, M. D., Brassard, A., & Kirsner, R. S. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0251-7 · Cited by 321 · cited 12×
“1c) is caused both by the underlying IBD (ulcerative colitis or more often Crohn’s disease, rarely other causes of stomies) and pathergy on the skinbearing appliances [20].”
BackgroundInfluentialPyoderma gangrenosum: a report of 44 cases with follow-up
Driesch, P. V. D. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.20022083.x · Cited by 319
Braun‐Falco, M., Kovnerystyy, O., Lohse, P., & Ruzicka, T. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.025 · Cited by 318 · cited 2×
“The clinical triad of PASH (PG, acne and suppurative hidradenitis) is an autoinflammatory syndrome [83, 84] that can be distinguished from PAPA by the absence of pyogenic sterile arthritis.”
BackgroundThe Inflammasomes and Autoinflammatory Syndromes
Broderick, L., De Nardo, D., Franklin, B. S., Hoffman, H. M., & Latz, E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040431 · Cited by 295 · cited 1×
“Indeed, various mutations have been described in genes encoding signalling molecules, including germline-encoded pattern recognition receptors, which are involved in triggering innate immune responses [101].”
BackgroundOrmerod, A. D., Thomas, K. S., Craig, F. E., Mitchell, E., Greenlaw, N., Norrie, J., Mason, J. M., Walton, S., Johnston, G. A., Williams, H. C., et al. (2015) · BMJ · doi:10.1136/bmj.h2958 · Cited by 273
Pathophysiology of pyoderma gangrenosum (PG): An updated review
Braswell, S. F., Kostopoulos, T. C., & Ortega-Loayza, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.06.021 · Cited by 271 · cited 3×
“IL-17 is a pivotal cytokine in regulating the innate immune response, but it is also crucial in autoinflammation recruiting neutrophils, activating them and stimulating their production of IL-8 [117].”
BackgroundLangan, S. M., Groves, R. W., Card, T. R., & Gulliford, M. C. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.130 · Cited by 257 · cited 6×
“Fatal outcome may result from the associated disease, visceral complication or localization [14] infectious events or iatrogenic complications [37].”
BackgroundInfluentialMarzano, A. V., Fanoni, D., Antiga, E., Quaglino, P., Caproni, M., Crosti, C., Meroni, P. L., & Cugno, M. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12394 · Cited by 242 · cited 2×
“The overproduction of MMPs is partially balanced by the overproduction of tissue inhibitor metalloproteinases; either way, the final result is equally a great inflammatory insult and the consequent destruction of the targeted tissue [113, 114].”
BackgroundSelf-citationIL-1β Drives Inflammatory Responses to Propionibacterium acnes In Vitro and In Vivo
Kistowska, M., Gehrke, S., Jankovic, D., Kerl, K., Fettelschoss, A., Feldmeyer, L., Fenini, G., Kolios, A., Navarini, A., Ganceviciene, R., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.438 · Cited by 233
Pyoderma gangrenosum: A review and update on new therapies
Miller, J., Yentzer, B. A., Clark, A., Jorizzo, J. L., & Feldman, S. R. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.030 · Cited by 232 · cited 1×
“Systematic reviews have primarily relied on anecdotal reports or retrospective case series [123, 124].”
BackgroundLima, A. L., Karl, I., Giner, T., Poppe, H., Schmidt, M., Presser, D., Goebeler, M., & Bauer, B. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14214 · Cited by 231
Brenner, M., Ruzicka, T., Plewig, G., Thomas, P., & Herzer, P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09404.x · Cited by 225 · cited 2×
“The experience in the treatment of neutrophilic diseases with these two drugs comes from anecdotal reports or small case series [131, 136].”
BackgroundBullous Pyoderma Gangrenosum and Leukemia
Perry, H. O. (1972) · Archives of Dermatology · doi:10.1001/archderm.106.6.901 · Cited by 219
Marzano, A. V., Damiani, G. B., Ceccherini, I., Berti, E., Gattorno, M., & Cugno, M. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15226 · Cited by 217
Self-citationMarzano, A. V., Trevisan, V., Gattorno, M., Ceccherini, I., De Simone, C., & Crosti, C. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.2907 · Cited by 211
Self-citationPropionibacterium acnes Induces IL-1β Secretion via the NLRP3 Inflammasome in Human Monocytes
Qin, M., Pirouz, A., Kim, M.-H., Krutzik, S. R., Garbán, H. J., & Kim, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.309 · Cited by 202
Anakinra for flares of pyogenic arthritis in PAPA syndrome
Dierselhuis, M. P. (2005) · Rheumatology · doi:10.1093/rheumatology/keh479 · Cited by 200
Clinical Features and Treatment of Peristomal Pyoderma Gangrenosum
Hughes, A. P., Jackson, J. M., & Callen, J. P. (2000) · JAMA · doi:10.1001/jama.284.12.1546 · Cited by 192 · cited 1×
“Bullous PG occurs often in patients with polycythemia vera, myelodysplasia or leukaemia and in these patients is indicative of a poor prognosis [26].”
BackgroundMarzano, A. V., Cugno, M., Trevisan, V, Fanoni, D., Venegoni, L., Berti, E., & Crosti, C. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04201.x · Cited by 190 · cited 1×
“The overproduction of MMPs is partially balanced by the overproduction of tissue inhibitor metalloproteinases; either way, the final result is equally a great inflammatory insult and the consequent destruction of the targeted tissue [113, 114].”
BackgroundSelf-citationClinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
J. Smith, E., Allantaz, F., Bennett, L., Zhang, D., Gao, X., Wood, G., L. Kastner, D., Punaro, M., Aksentijevich, I., Pascual, V., et al. (2010) · Current Genomics · doi:10.2174/138920210793175921 · Cited by 179 · cited 1×
“Severe nodulocystic acne and PG tend to develop around puberty and may persist into adulthood [79].”
BackgroundPyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation
Marzano, A. V., Borghi, A., Meroni, P. L., & Cugno, M. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14691 · Cited by 176 · cited 1×
“PGmay occur in the context of rare, genetic autoinflammatory syndromes such as PAPA (pyogenic arthritis, PG and acne), PASH (PG, acne and suppurative hidradenitis) or PAPASH (pyogenic arthritis, acne, PG and suppurative hidradenitis) [12, 13].”
BackgroundSelf-citationPAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment
Cugno, M., Borghi, A., & Marzano, A. V. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0265-1 · Cited by 162 · cited 1×
“PGmay occur in the context of rare, genetic autoinflammatory syndromes such as PAPA (pyogenic arthritis, PG and acne), PASH (PG, acne and suppurative hidradenitis) or PAPASH (pyogenic arthritis, acne, PG and suppurative hidradenitis) [12, 13].”
BackgroundSelf-citationAlarmins, inflammasomes and immunity
Ojcius, D., & Saïd-Sadier, N. (2012) · Biomedical Journal · doi:10.4103/2319-4170.104408 · Cited by 161 · cited 1×
“These are recognized by specific receptors [104] such as NLRP3,”
BackgroundPropionibacterium acnes Activates the NLRP3 Inflammasome in Human Sebocytes
Li, Z. J., Choi, D. K., Sohn, K., Seo, M. S., Lee, H. E., Lee, Y., Seo, Y., Lee, Y., Shi, G., Zouboulis, C. C., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.221 · Cited by 160
Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome Maps to Chromosome 15q
Yeon, H. B., Lindor, N. M., Seidman, J. G., & Seidman, C. E. (2000) · The American Journal of Human Genetics · doi:10.1086/302866 · Cited by 156 · cited 1×
“Mutated PSPPIP-1 leads to decreased inhibition of the inflammasome and consequent activation of caspase1, which in turn leads to an increased production of IL-1β that drives the autoinflammation associated with the PAPA triad [107].”
BackgroundMarzano, A. V., Ceccherini, I., Gattorno, M., Fanoni, D., Caroli, F., Rusmini, M., Grossi, A., SIMONE, C. D., Borghi, M. O., Meroni, P. L., et al. (2014) · Medicine · doi:10.1097/md.0000000000000187 · Cited by 151 · cited 5×
“clinical features, especially acne, usually occurring at puberty [83, 84, 91, 92].”
BackgroundInfluentialSelf-citationMarzano, A. V., Ishak, R. S., Saibeni, S., CROSTI, C., Meroni, P. L., & Cugno, M. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8351-x · Cited by 140 · cited 4×
“Two different groups [21, 34] proposed similar diagnostic criteria which are reported in Table 2.”
BackgroundInfluentialSelf-citationCutaneous Manifestations in Patients With Inflammatory Bowel Diseases
Marzano, A. V., Borghi, A., Stadnicki, A., CROSTI, C., & Cugno, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436959.62286.f9 · Cited by 136 · cited 10×
“1c) is caused both by the underlying IBD (ulcerative colitis or more often Crohn’s disease, rarely other causes of stomies) and pathergy on the skinbearing appliances [20].”
BackgroundInfluentialSelf-citationDramatic Improvement of Pyoderma Gangrenosum with Infliximab in a Patient with PAPA Syndrome
Stichweh, D., Punaro, M., & Pascual, V. (2005) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2005.22320.x · Cited by 132
Canakinumab in adults with steroid‐refractory pyoderma gangrenosum
Kolios, A. G. A., Maul, J., Meier-Schiesser, B., Kerl, K., Traidl‐Hoffmann, C., Hertl, M., Zillikens, D., Röcken, M., Ring, J., Facchiano, A., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14037 · Cited by 116 · cited 2×
“Canakinumab is administered subcutaneously at a dose of 150 mg at week 0 and week 2 with a possible repeated injection at week 8 in case of poor response [136].”
BackgroundPeculiarities of PAPA syndrome
Tallon, B., & Corkill, M. (2006) · Rheumatology · doi:10.1093/rheumatology/kei178 · Cited by 110
Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., Church, M. K., & Maurer, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.041 · Cited by 106 · cited 1×
“Canakinumab is usually well tolerated; side effects include hypertensive episodes, lumbago and infections [137].”
BackgroundThompson, D. F., & Montarella, K. E. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h563 · Cited by 102
Hidradenitis suppurrativa (acne inversa) as a systemic disease
Dessinioti, C., Katsambas, A., & Antoniou, C. (2013) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.11.006 · Cited by 98
The skin pathergy test: innately useful?
Varol, A., Seifert, O., & Anderson, C. D. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-1008-9 · Cited by 95
The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum
Caproni, M., Antiga, E., Volpi, W., Verdelli, A., Venegoni, L., Quaglino, P., Fabbri, P. V., & Marzano, A. V. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13670 · Cited by 90 · cited 1×
“of T regulatory cells and T helper 17 effector cells in patients with PG has been described [118].”
BackgroundSelf-citationGeusau, A., Mothes‐Luksch, N., Nahavandi, H., Pickl, W. F., Wise, C. A., Pourpak, Z., Ponweiser, E., Eckhart, L., & Sunder‐Plaßmann, R. (2013) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.717 · Cited by 89
Calderón‐Castrat, X., Bancalari-Díaz, D., Román‐Curto, C., Romo-Melgar, A., Amorós, D., Alcaraz-Más, L., Fernández‐López, E., & Cañueto, J. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14383 · Cited by 81
Are neutrophilic dermatoses autoinflammatory disorders?
Satoh, T. K., Mellett, M., Contassot, E., & French, L. E. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15105 · Cited by 80 · cited 1×
“targeted anti-IL-1 therapies in a variety of diseases, has led to an extension of the concept of autoinflammation [98].”
BackgroundThomas, K. S., Ormerod, A. D., Craig, F. E., Greenlaw, N., Norrie, J., Mitchell, E., Mason, J. M., Johnston, G. A., Wahie, S., Williams, H. C., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.016 · Cited by 67
Clinical Efficacy of Etanercept for Treatment of PAPA Syndrome
Tofteland, N. D., & SHAVER, T. S. (2010) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3181e969b9 · Cited by 65
An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Pazyar, N., Feily, A., & Yaghoobi, R. (2012) · Current Clinical Pharmacology · doi:10.2174/157488412803305821 · Cited by 60
Burkett, P. R., & Kuchroo, V. K. (2016) · Cell · doi:10.1016/j.cell.2016.11.044 · Cited by 60
Jaeger, T., ANDRES, C., Grosber, M., Zirbs, M., Hein, R., Ring, J., & Traidl‐Hoffmann, C. (2013) · European Journal of Dermatology · doi:10.1684/ejd.2013.2018 · Cited by 55
Marzano, A. V., Cugno, M., Trevisan, V., Lazzari, R., Fanoni, D., Berti, E., & CROSTI, C. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400218 · Cited by 54 · cited 1×
“It is noteworthy that IL-1β, IL-17 and TNF-α are also elevated in the lesional skin of other neutrophilic dermatoses, including SS and APF [69, 119, 120].”
BackgroundSelf-citationBarbosa, N. S., Tolkachjov, S. N., el‐Azhary, R. A., Davis, M. D. P., Camilleri, M., McEvoy, M. T., Bridges, A. G., & Wetter, D. A. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.05.044 · Cited by 53
Neutrophilic dermatoses and autoinflammatory diseases with skin involvement—innate immune disorders
Navarini, A. A., Satoh, T. K., & French, L. E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0549-6 · Cited by 50
Pyoderma gangrenosum: pathogenetic oriented treatment approaches
Wollina, U., & Tchernev, G. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0285-x · Cited by 41
van der Zee, H. H., Horváth, B., Jemec, G. B. E., & Prens, E. P. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.102 · Cited by 39
Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation
Palanivel, J. A., Macbeth, A. E., & Levell, N. J. (2012) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2012.04375.x · Cited by 36
Marzano, A. V., Tavecchio, S., Berti, E., Gelmetti, C. M., & Cugno, M. (2015) · Medicine · doi:10.1097/md.0000000000001818 · Cited by 30
Self-citationHeymann, M. C., & Rösen‐Wolff, A. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.006 · Cited by 26
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds
Marzano, A. V., Tavecchio, S., Berti, E., Gelmetti, C. M., & Cugno, M. (2015) · Medicine · doi:10.1097/md.0000000000002301 · Cited by 26
Self-citationSHP-1 and IL-1α conspire to provoke neutrophilic dermatoses
Lukens, J. R., & Kanneganti, T. (2014) · Rare Diseases · doi:10.4161/rdis.27742 · Cited by 20
Cited by
Maverakis, E., Marzano, A. V., Le, S. T., Callen, J. P., Brüggen, M.-C., Guenova, E., Dissemond, J., Shinkai, K., & Langan, S. M. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0213-x · Cited by 285
Self-citationOrganization of the skin immune system and compartmentalized immune responses in infectious diseases
Quaresma, J. A. S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-18 · Cited by 149
Haskamp, S., Bruns, H., Hahn, M., Hoffmann, M., Gregor, A., Löhr, S., Hahn, J., Schauer, C., Ringer, M., Flamann, C., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.07.001 · Cited by 84
“, due to certain drugs.(1) Generalized pustular psoriasis (GPP [MIM: 614204]) is a genetic condition characterized by altered neutrophil function leading to sterile neutrophil pustules.”
BackgroundNew treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review
Yamanaka, K. (2024) · The Journal of Dermatology · doi:10.1111/1346-8138.17031 · Cited by 19
Metadata
- Authors
- Marzano, A. V., Borghi, A., Wallach, D., & Cugno, M.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2017-07-07
- Volume
- 54
- Issue
- 1
- Pages
- 114-130
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W2725763230
- Cited by
- 163
- References
- 76
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.